Replies to post #8185 on GTC Biotherapeutics (fka GTCB)

[dodah_2]

The dilution per se is not the problem... at least for me. The problem or perception of such is that the company appears to have been hoist by its own petard. The company expected upfront money from its forthcoming partner, announced same in its revenue projections, and failed to deliver. In Dr. Cox's presentation yesterday, he made the comment that the outcome for partnerships and the negotiations leading to such were very difficult to predict (or words to that effect). I think Dr. Cox is doing his best to encourage stockholders and the investment community, and I believe he is generally very conservative in his public pronouncements, but I wish he had considered his comment yesterday...earlier.

[exwannabe]

Jessey, you are way off base.

To start, not only am I not bitching about the PPS and paper loss on such, I bought more on the dip and if things go well I will make a larger profit thereby. You are really projecting something on to me when you imply I am just unhappy, as I am not in the least. I quite well understand that investing in ANY startup biotech carries a risk of total loss.

Should I have sean it comming? Good question. I certainly did see a reasonable chance of a serious hit due to financing. I did not want to be out of the stock though because I certainly thought they had a good chance to get the partnership deal. I did keep extra cash ready just in case. I am very willing to roll the dice and take the hit.

I never accused Cox and co. of being morons, I said they got the decision wrong. As a Monday morning quarterback, I AM a genius :-)

The issue is not who/what/where. It happened and I could care less exactly why. All I care about is that management sees that they will be quickly in the same position, and hopefully have it better planned.

BTW, anybody who cares about the Safe Habor statement is more naive than my 10 year old daughter.